Presence of Tumour-infiltrating FOXP3+ Lymphocytes Correlates with Immature Tumour Angiogenesis in Renal Cell Carcinomas |
Zhan, Hai-Lun
(Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University)
Gao, Xin (Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University) Zhou, Xiang-Fu (Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University) Pu, Xiao-Yong (Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University) Wang, De-Juan (Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University) |
1 | Herbst C, Kosmehl H, Stiller KJ, et al (1998). Evaluation of microvessel density by computerized image analysis in human renal cell carcinoma. Correlation to pT category, nuclear grade, proliferative activity and occurrence of metastasis. J Cancer Res Clin Oncol, 124, 141-7. DOI |
2 | Hori S, Sakaguchi S (2004). Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect, 6, 745-51. DOI |
3 | Kinouchi T, Mano M, Matsuoka I, et al (2003). Immature tumor angiogenesis in high-grade and high-stage renal cell carcinoma. Urology, 62, 765-70. DOI |
4 | Kirkali Z, Yorukoglu K, Ozkara E, Kazimoglu H, Mungan U (2001). Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma. Int J Urol, 8, 697-703. DOI |
5 | Ko JS, Zea AH, Rini BI, et al (2009). Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res, 15, 2148-57. DOI |
6 | Kohler HH, Barth PJ, Siebel A, Gerharz EW, Bittinger A (1996). Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol, 77, 650-4. DOI |
7 | Li B, Lalani AS, Harding TC, et al (2006). Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy. Clin Cancer Res, 12, 6808-16. DOI ScienceOn |
8 | Liyanage UK, Moore TT, Joo HG, et al (2002). Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol, 169, 2756-61. DOI |
9 | Qian CN, Huang D, Wondergem B, Teh BT (2009). Complexity of tumor vasculature in clear cell renal cell carcinoma. Cancer, 115(10 Suppl), 2282-9. DOI |
10 | Alvaro T, Lejeune M, Salvado MT, et al (2005). Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res, 11, 1467-73. DOI |
11 | Bates GJ, Fox SB, Han C, et al (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol, 24, 5373-80. DOI ScienceOn |
12 | Cesana GC, DeRaffele G, Cohen S, et al (2006). Characterization of CD4+CD25+regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol, 24, 1169-77. DOI |
13 | Dace DS, Khan AA, Kelly J, Apte RS (2008). Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One, 3, e3381. DOI |
14 | Dekel Y, Koren R, Kugel V, Livne PM, Gal R (2002). Significance of angiogenesis and microvascular invasion in renal cell carcinoma. Pathol Oncol Res, 8, 129-32. DOI |
15 | Delahunt B, Bethwaite PB, Thornton A (1997). Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol, 80, 401-4. DOI |
16 | Finke JH, Rini B, Ireland J, et al (2008). Sunitinib reverses type- 1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients. Clin Cancer Res, 14, 6674-82. DOI |
17 | Gabrilovich D, Ishida T, Oyama T, et al (1998). Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92, 4150-66. |
18 | Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1, 27-31. DOI ScienceOn |
19 | Fontenot JD, Rudensky AY (2005). A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol, 6, 331-7. DOI ScienceOn |
20 | Fuhrman SA, Lasky LC, Limas C (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol, 6, 655-63. DOI |
21 | Gaengel K, Genové G, Armulik A, Betsholtz C (2009). Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol, 29, 630-8. DOI |
22 | Gerhardt H, Semb H (2008). Pericytes: gatekeepers in tumour cell metastasis? J Mol Med (Berl), 86, 135-44. DOI |
23 | Giatromanolaki A, Bates GJ, Koukourakis MI, et al (2008). The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol, 110, 216-21. DOI |
24 | Griffiths RW, Elkord E, Gilham DE, et al (2007). Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. Cancer Immunol Immunother, 56, 1743-53. DOI |
25 | Gupta S, Joshi K, Wig JD, Arora SK (2007). Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Acta Oncol, 46, 792-7. DOI ScienceOn |
26 | Siddiqui SA, Frigola X, Bonne-Annee S, et al (2007). Tumorinfiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res, 13, 2075-81. DOI |
27 | Sabo E, Boltenko A, Sova Y, et al (2001a). Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res, 7, 533-7. |
28 | Sabo E, Boltenko A, Sova Y, et al (2001b). Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res, 7, 533-7 |
29 | Seo N, Hayakawa S, Takigawa M, Tokura Y (2001). Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology, 103, 449-57. DOI |
30 | Suzuki K, Morita T, Hashimoto S, Tokue A (2001). Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma. Urol Res, 29, 7-12. DOI |
31 | Thornton AM, Shevach EM (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med, 188, 287-96. DOI ScienceOn |
32 | Yao X, Qian CN, Zhang ZF, et al (2007). Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res, 13, 161-9. DOI |
33 | Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY (2008). Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int, 101, 758-64. DOI |
34 | Yoshino S, Kato M, Okada K (1995). Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol, 2, 156-60. DOI ScienceOn |
![]() |